Rationale of mesenchymal stem cell therapy in kidney injury

American Journal of Kidney Diseases

Volumn 61, Issue 2, 2013, Pages 300-309

  Cantaluppi, Vincenzo ^a   Biancone, Luigi ^a   Quercia, Alessandro ^a   Deregibus, Maria Chiara ^a   Segoloni, Giuseppe ^a   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

kidney injury; kidney transplantation; Mesenchymal stem cells; rejection

Indexed keywords

5' NUCLEOTIDASE; BASILIXIMAB; CALCINEURIN INHIBITOR; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; CREATININE; CYCLOSPORIN; ENDOGLIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HLA ANTIBODY; HLA DR ANTIGEN; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SOMATOMEDIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR PAX2; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; VIMENTIN;

ACUTE GRAFT REJECTION; ADULT; APOPTOSIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BIOLOGICAL ACTIVITY; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; LYMPHOCYTE FUNCTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; OLIGURIA; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE REGENERATION; URINE VOLUME;

ACUTE KIDNEY INJURY; HUMANS; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; REPERFUSION INJURY;

EID: 84872278671     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.05.027     Document Type: Article

References (87)

1. J.V. Bonventre, L. Yang Cellular pathophysiology of ischemic acute kidney injury J Clin Invest 121 11 2011 4210 4221
2. B. Schröppel, P.S. Heeger Gazing into a crystal ball to predict kidney transplant outcome J Clin Invest 120 6 2010 1803 1806
3. J.M. Cecka The UNOS Scientific Renal Transplant Registry - ten years of kidney transplants Clin Transpl 1997 1 14
4. S.G. Yarlagadda, S.G. Coca, R.N. Formica Jr, E.D. Poggio, C.R. Parikh Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis Nephrol Dial Transplant 24 2009 1039 1047
5. N. Perico, D. Cattaneo, M.H. Sayegh, G. Remuzzi Delayed graft function in kidney transplantation Lancet 364 9447 2004 1814 1827
6. B.J. Nankivell, S.I. Alexander Rejection of the kidney allograft N Engl J Med 363 15 2010 1451 1462
7. P.F. Halloran T-Cell mediated rejection of kidney transplants: a personal viewpoint Am J Transplant 10 5 2010 1126 1134
8. S. Mauiyyedi, R.B. Colvin Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment Curr Opin Nephrol Hypertens 11 6 2002 609 618
9. P.F. Halloran, A. Wadgymar, S. Ritchie, J. Falk, K. Solez, N.S. Srinivasa The significance of the anti-class I antibody response Clinical and pathologic features of anti-class I mediated rejection Transplantation 49 1 1990 85 91
10. R.B. Colvin, T. Hirohashi, A.B. Farris, F. Minnei, A.B. Collins, R.N. Smith Emerging role of B cells in chronic allograft dysfunction Kidney Int Suppl 119 2010 S13 S17
11. C.J. Pino, H.D. Humes Stem cell technology for the treatment of acute and chronic renal failure Transl Res 156 3 2010 161 168
12. M. Dominici, K. Le Blanc, I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells The International Society for Cellular Therapy position statement Cytotherapy 8 4 2006 315 317
13. M. Gnecchi, H. He, O.D. Liang Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 4 2005 367 368
14. J. Moore, S. Shabir, S. Chand Assessing and comparing rival definitions of delayed renal allograft function for predicting subsequent graft failure Transplantation 90 10 2010 1113 1116
15. A. Tong, J.R. Chapman, G. Wong, J. De Bruijn, J.C. Craig Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines Transplantation 92 9 2011 962 972
16. M. Kosieradzki, W. Rowiński Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention Transplant Proc 40 10 2008 3279 3288
17. D.A. Shoskes, P.F. Halloran Delayed graft function in renal transplantation: etiology, management and long-term significance J Urol 155 6 1996 1831 1840
18. M.L. Nicholson, T.J. Wheatley, T. Horsburgh, C.M. Edwards, P.S. Veitch, P.R. Bell The relative influence of delayed graft function and acute rejection on renal transplant survival Transpl Int 9 4 1996 415 419
19. J. Pascual, J. Zamora, J.D. Pirsch A systematic review of kidney transplantation from expanded criteria donors Am J Kidney Dis 52 3 2008 553 586
20. A.O. Ojo Expanded criteria donors: process and outcomes Semin Dial 18 6 2005 463 468
21. D. Linfert, T. Chowdhry, H. Rabb Lymphocytes and ischemia-reperfusion injury Transplant Rev (Orlando) 23 1 2009 1 10
22. A.M. Sheridan, J.V. Bonventre Cell biology and molecular mechanisms of injury in ischemic acute renal failure Curr Opin Nephrol Hypertens 9 4 2000 427 434
23. N.E. Kieran, H. Rabb Immune responses in kidney preservation and reperfusion injury J Investig Med 52 5 2004 310 314
24. T.A. Sutton, C.J. Fisher, B.A. Molitoris Microvascular endothelial injury and dysfunction during ischemic acute renal failure Kidney Int 62 5 2002 1539 1549
25. K. Krejci, T. Tichy, P. Bachleda, J. Zadrazil Calcineurin inhibitor-induced renal allograft nephrotoxicity Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154 4 2010 297 306
26. K.D. Liu, P.R. Brakeman Renal repair and recovery Crit Care Med 36 suppl 4 2008 S187 S192
27. M. Abbate, G. Remuzzi Acceleration of recovery in acute renal failure: from cellular mechanisms of tubular repair to innovative targeted therapies Ren Fail 18 3 1996 377 388
28. C. Ponticelli The mechanisms of acute transplant rejection revisited J Nephrol 25 2 2012 150 158
29. N.M. Rogers, T.J. Matthews, J.Y. Kausman, A.R. Kitching, P.T. Coates Kidney dendritic cells: their role in homeostasis, inflammation and transplantation Nephrology (Carlton) 14 7 2009 625 635
30. S. De Haij, A.M. Woltman, L.A. Trouw Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1 Kidney Int 68 5 2005 2091 2102
31. S.J. Knechtle Immunoregulation and tolerance Transplant Proc 42 suppl 9 2010 S13 S15
32. K.J. Wood Regulatory T cells in transplantation Transplant Proc 43 6 2011 2135 2136
33. J.M. Mosquera Reboredo, E. Vázquez Martul Diagnostic criteria of antibody-mediated rejection in kidney transplants Nefrologia 31 4 2011 382 391
34. B.A. Wasowska Mechanisms involved in antibody- and complement-mediated allograft rejection Immunol Res 47 1-3 2010 25 44
35. L.G. Hidalgo, B. Sis, J. Sellares NK cell transcripts and NK cells in kidney biopsies from patients with donor specific antibodies: evidence for NK cell involvement in antibody mediated rejection Am J Transplant 10 8 2010 1812 1822
36. B. Delorme, J. Ringe, N. Gallay Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells Blood 111 5 2008 2631 2635
37. F. Collino, S. Bruno, M.C. Deregibus, C. Tetta, G. Camussi MicroRNAs and mesenchymal stem cells Vitam Horm 87 2011 291 320
38. C. Lange, F. Tögel, H. Ittrich Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats Kidney Int 68 4 2005 1613 1617
39. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange, C. Westenfelder Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms Am J Physiol Renal Physiol 289 1 2005 F31 F42
40. F. Tögel, Y. Yang, P. Zhang, Z. Hu, C. Westenfelder Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury Am J Physiol Renal Physiol 295 1 2008 F315 F321
41. R.F. Wynn, C.A. Hart, C. Corradi-Perini A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow Blood 104 9 2004 2643 2645
42. J.F. Ji, B.P. He, S.T. Dheen, S.S. Tay Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury Stem Cells 22 3 2004 415 427
43. F. Tögel, J. Isaac, Z. Hu, K. Weiss, C. Westenfelder Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury Kidney Int 67 5 2005 1772 1784
44. H. Gao, W. Priebe, J. Glod, D. Banerjee Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium Stem Cells 27 4 2009 857 865
45. G. Valentin, P. Haas, D. Gilmour The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b Curr Biol 17 12 2007 1026 1031
46. C. Dambly-Chaudière, N. Cubedo, A. Ghysen Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1 BMC Dev Biol 7 2007 23
47. H. Zhu, N. Mitsuhashi, A. Klein The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix Stem Cells 24 4 2006 928 935
48. M.B. Herrera, B. Bussolati, S. Bruno Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury Kidney Int 72 4 2007 430 441
49. R.S. Lindoso, D.S. Araujo, J. Adão-Novaes Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells Cell Physiol Biochem 28 2 2011 267 278
50. M. Morigi, B. Imberti, C. Zoja Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure J Am Soc Nephrol 15 7 2004 1794 1804
51. M. Morigi, M. Introna, B. Imberti Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice Stem Cells 26 8 2008 2075 2082
52. M.B. Herrera, B. Bussolati, S. Bruno, V. Fonsato, G.M. Romanazzi, G. Camussi Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury Int J Mol Med 14 6 2004 1035 1041
53. J.S. Duffield, K.M. Park, L.L. Hsiao Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells J Clin Invest 115 7 2005 1743 1755
54. S. Choi, M. Park, J. Kim, S. Hwang, S. Park, Y. Lee The role of mesenchymal stem cells in the functional improvement of chronic renal failure Stem Cells Dev 18 3 2009 521 529
55. P.V. Hauser, R. De Fazio, S. Bruno Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery Am J Pathol 177 4 2010 2011 2021
56. B.D. Humphreys, M.T. Valerius, A. Kobayashi Intrinsic epithelial cells repair the kidney after injury Cell Stem Cell 2 3 2008 284 291
57. S. Ishibe, L.G. Cantley Epithelial-mesenchymal-epithelial cycling in kidney repair Curr Opin Nephrol Hypertens 17 4 2008 379 385
58. B. Bi, R. Schmitt, M. Israilova, H. Nishio, L.G. Cantley Stromal cells protect against acute tubular injury via an endocrine effect J Am Soc Nephrol 18 9 2007 2486 2496
59. A.I. Caplan, J.E. Dennis Mesenchymal stem cells as trophic mediators J Cell Biochem 98 5 2006 1076 1084
60. B. Imberti, M. Morigi, S. Tomasoni Insulin-like growth factor-1 sustains stem cell mediated renal repair J Am Soc Nephrol 18 11 2007 2921 2928
61. F. Tögel, P. Zhang, Z. Hu, C. Westenfelder VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury J Cell Mol Med 13 8B 2009 2109 2114
62. D.P. Basile The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function Kidney Int 72 2 2007 151 156
63. S. Aggarwal, M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 4 2005 1815 1822
64. A. Bartholomew, C. Sturgeon, M. Siatskas Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 30 1 2002 42 48
65. M. Di Nicola, C. Carlo-Stella, M. Magni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 10 2002 3838 3843
66. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener, D. Dilloo Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 12 2004 4619 4621
67. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka, E.C. Guinan Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 3 2003 389 397
68. Z. Selmani, A. Naji, I. Zidi Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells Stem Cells 26 1 2008 212 222
69. K. Le Blanc, I. Rasmusson, B. Sundberg Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 9419 2004 1439 1441
70. H. Li, Z. Guo, X. Jiang, H. Zhu, X. Li, N. Mao Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease Stem Cells 26 10 2008 2531 2541
71. D. García-Olmo, M. García-Arranz, D. Herreros, I. Pascual, C. Peiro, J.A. Rodríguez-Montes A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation Dis Colon Rectum 48 7 2005 1416 1423
72. F. Casiraghi, N. Azzollini, P. Cassis Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells J Immunol 181 6 2008 3933 3946
73. G. Camussi, M.C. Deregibus, S. Bruno, V. Cantaluppi, L. Biancone Exosomes/microvesicles as a mechanism of cell to cell communication Kidney Int 78 9 2010 838 848
74. S. Bruno, C. Grange, M.C. Deregibus Mesenchymal stem cell-derived microvesicles protect against acute tubular injury J Am Soc Nephrol 20 5 2009 1053 1067
75. F. Collino, M.C. Deregibus, S. Bruno Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs PLoS One 5 7 2010 e11803
76. J. Ratajczak, K. Miekus, M. Kucia Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery Leukemia 20 5 2006 847 856
77. J.M. Aliotta, F.M. Sanchez-Guijo, G.J. Dooner Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation Stem Cells 25 9 2007 2245 2256
78. M.C. Deregibus, V. Cantaluppi, R. Calogero Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA Blood 110 7 2007 2440 2448
79. S. Gatti, S. Bruno, M.C. Deregibus Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury Nephrol Dial Transplant 26 5 2011 1474 1483
80. N. Sakata, N.K. Chan, J. Chrisler, A. Obenaus, E. Hathout Bone marrow cell cotransplantation with islets improves their vascularization and function Transplantation 89 6 2010 686 693
81. N. Perico, F. Casiraghi, M. Introna Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility Clin J Am Soc Nephrol 6 2 2011 412 422
82. J. Tan, W. Wu, X. Xu Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial JAMA 307 11 2012 1169 1177
83. F. Tögel, C. Westenfelder Mesenchymal stem cell: a new therapeutic tool for AKI Nat Rev Nephrol 6 3 2010 179 183
84. D.J. Prockop, S.D. Olson Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions Blood 109 8 2007 3147 3151
85. M. Breitbach, T. Bostani, W. Roell Potential risks of bone marrow cell transplantation into infarcted hearts Blood 110 4 2007 1362 1369
86. M.W. Epperly, H. Guo, J.E. Gretton, J.S. Greenberger Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis Am J Respir Cell Mol Biol 29 2 2003 213 224
87. U. Kunter, S. Rong, P. Boor Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes J Am Soc Nephrol 18 6 2007 1754 1764